1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. SANARA MEDTECH INC
Sanara MedTech Inc
XNAS: SMTI
Expensive Rocket
Download real time
33.16-1.93(-5.50%)
New 52W High in past week
741.6K
XNAS Volume
High volume+loss today

XNAS 16 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Sanara MedTech Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Sanara MedTech Inc share price target, revenues, EPS, net income and more

Sanara MedTech Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • POSITIVE

    Quarterly Revenue Sanara MedTech Inc Jun-2026 Quarterly Revenue is $28 Million which is growth of 8.9% YoY.

  • POSITIVE

    Quarterly Net Profit Sanara MedTech Inc Jun-2026 Quarterly Net Profit is $-0 Million which is growth of 77.5% YoY.

Sanara MedTech Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
28.127.827.626.325.823.426.321.720.218.517.71615.8
Cost Of Rev.
21.91.91.91.91.82.3221.91.81.82.2
Gross Profit
26.225.925.724.523.921.624.119.718.216.715.914.313.6
⌄
24.423.222.821.523.923.726.421.521.118.218.115.915.8
Operating Profit
1.82.72.92.9-0-2.1-2.4-1.8-2.9-1.6-2.2-1.6-2.2
⌄
-1.8-1.8-1.8-1.8-1.8-1.3-1.3-0.9-0.6-0.3-0.3-0.2
Profit Before Tax
-0.40.4-1.10.8-2-3.5-1.7-2.9-3.5-1.8-0.3-1.1-1.9
Tax
----------
⌄
-0.50.5-1.6-30.4-2-3.5-1.5-2.9-3.5-1.8-0.2-1.1-1.8
Diluted NI Avail to Com Stockholders Ann.
-0.50.5-1.6-30.4-2-3.5-1.5-2.9-3.5-1.8-0.2-1.1-1.8
Basic EPS
-0.10.1-0.2-3.5-0.2-0.4-0.2-0.3-0.4-0.2-0-0.1-0.2
Diluted EPS After ExtraOrdinary
-0.100.10.1-0.2-0.4-0.4-0.3-0.4-0.2-0.3-0.2-0.3
Number Of Shares End
8.78.78.78.78.68.68.58.58.58.48.48.38.2
Net Income Continuing Discontinued Operations
-0.50.5-1.6-30.4-2-3.5-1.5-2.9-3.5-1.8-0.2-1.1-1.8
Normalized Income
1.21.321.9-0.5-2.1-2.1-1.6-2-1-1.4-0.8-1.1
Interest Income
0.100------
Interest
1.81.81.81.81.81.31.30.90.60.30.30.2
Net Interest Income
-1.8-1.8-1.8-1.8-1.8-1.3-1.3-0.9-0.6-0.3-0.3-0.2
EBIT
1.42.20.72.7-0.2-2.2-0.4-2-2.9-1.50-0.9-1.9
EBITDA
22.81.43.70.9-1.11.2-0.9-1.8-0.41.10.1-1.1
Reconciled Cost Of Rev.
21.91.91.51.91.82.3221.91.81.82.2
Reconciled Depr.
0.60.60.711.11.11.61.11.11.11.110.8
Profit From Continuing Operations
-0.50.5-1.6-30.4-2-3.5-1.7-2.9-3.5-1.8-0.3-1.1-1.9
Normalized EBITDA
22.83.23.70.9-1.1-0.8-0.7-1.8-0.5-1.1-0.6-1.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Sanara MedTech Inc competitor comparison and performance snapshot within industry

Sanara MedTech Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue Sanara MedTech Inc Dec-2025 Annual Revenue is $103 Million which is growth of 19.0% YoY.

  • NEGATIVE

    Annual Net Profit Sanara MedTech Inc Dec-2025 Annual Net Profit is $-38 Million which is growth of -288.7% YoY.

Sanara MedTech Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
31.1%
45.9%
 103.186.76545.824.115.611.85.86.35.53.4
Cost Of Rev. Ann.
5.4%
36.2%
7.77.58.17.96.42.31.61.20.50.80.90.9
Gross Profit Ann.
34.3%
46.8%
102.295.678.557.139.521.81410.65.35.54.62.5
Operating Exp. Ann.
18.7%
35.4%
91.986.587.264.851.729.21913.25.85.44.83.5
Operating Profit Ann.
-
-
10.39.2-8.7-7.7-12.2-7.4-5-2.6-0.50.1-0.3-1
⌄
-
-
-7.2-6.8-3.1-0.5-0.3-0-0.1-0.1-0.1-0.2-0.2
Other Exp. Ann.
-
-
 -2.81.93.7-1.4-0.60.6-0.1-00.30-0.2
PBT Ann.
-
-
-0.3-0.4-9.9-4.4-13.9-8-4.5-2.8-0.60.3-0.4-1.3
Tax Ann.
-
-
 ---5.8-------
⌄
-
-
-32-37.6-9.7-4.3-7.9-7.9-4.4-2.8-0.70.2-0.7-1.6
Diluted NI Avail to Com Stockholders Ann.
-
-
-32-37.6-9.7-4.3-7.9-7.9-4.4-2.8-0.70.2-0.7-1.6
EPS Ann.
-
-
 -4.4-1.1-0.5-1-1.1-0.8-1.6-0.30.2-0.6-1.5
Diluted EPS Ann.
-
-
 -4.4-1.1-0.5-1-1.1-0.8-1.6-0.30.1-0.6-1.5
Number Of Shares End
2.4%
8.4%
 8.78.58.48.17.55.81.72.41.11.11.1
Total Exp. Ann.
17.4%
35.5%
 9495.372.758.131.520.614.46.36.25.84.3
Net Income Continuing Discontinued Operations Ann.
-
-
-32-37.6-9.7-4.3-7.9-7.9-4.4-2.8-0.60.3-0.4-1.3
Normalized Income Ann.
-
-
6.333.6-6.8-4.5-4.9-5.3-3.6-2.7-0.60.10.3-1.1
Interest Income Ann.
-
-
0.10--------
Interest Ann.
183%
-
7.36.83.10.50.300.10.10.10.20.2
EBITDA Ann.
-
-
9.810.3-1.9-0.3-11.3-7.4-4.1-2.6-0.40.5-0.2-1.1
Reconciled Cost Of Rev. Ann.
-1.1%
31.1%
7.26.28.17.96.42.31.61.20.50.80.90.9
Reconciled Depr. Ann.
18.6%
67.9%
2.944.93.72.40.60.30.10.10.10.10.1
Profit From Continuing Operations Ann.
-
-
-32-37.6-9.9-4.4-8.1-8-4.5-2.8-0.60.3-0.4-1.3
Normalized EBITDA Ann.
-
-
11.712.1-3.8-4-10.2-7.4-4.7-2.5-0.40.2-0.2-0.9
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
18.9%
2Y CAGR
25.9%
3Y CAGR
31.1%
5Y CAGR
45.9%
7Y CAGR
50.9%
10Y CAGR
40.7%
Total Revenue Annual growth is lower than historical averages.
Operating Exp. Ann.
1Y CHG
-0.8%
2Y CAGR
15.5%
3Y CAGR
18.7%
5Y CAGR
35.4%
7Y CAGR
47.1%
10Y CAGR
37.8%
Operating Expenses Annual Cr is falling faster than historical averages.

Sanara MedTech Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund Sanara MedTech Inc Dec-2025 Total Shareholders Fund is $6 Million which is growth of -84.9% YoY.

  • NEGATIVE

    Total Assets Sanara MedTech Inc Dec-2025 Total Assets is $73 Million which is growth of -17.2% YoY.

Sanara MedTech Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
6.1%
49.4%
72.988.173.96136.49.811.132.22.21.4
⌄
51.4%
75.7%
6749.229.319.36.244.71.92.12.62.7
⌄
-47.9%
-1%
5.939.444.841.830.66.2-4.81.1-0.8-1.3-2.1
Total Capitalization Ann.
7.5%
53%
51.970.15441.830.66.28.12.60.10.8-0.1
Tangible Assets Ann.
-
-
-16.3-5.2-3.76.725.93.15.11.1-0-0.6-1.5
Working Capital Ann.
24.1%
75.3%
14.9185.27.818.60.96.20.6-0.10.6-0.3
Invested Capital Ann.
7.5%
53%
51.970.154.541.830.66.2-3.32.60.50.3-0.3
Tangible Book Value Ann.
-
-
-16.3-5.2-3.76.725.93.1-6.21.1-0.9-1.4-2.3
Borrowings Ann.
292%
149.4%
48.232.311.80.80.40.52.11.51.21.61.8
Net Debt Ann.
-
-
29.414.84.6----0.80.70.81.6
Share Issued Ann.
2.7%
7.4%
98.88.58.37.76.33.62.41.11.11.1
Number Of Shares End
2.4%
8.4%
8.78.58.48.17.55.81.72.41.11.11.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-17.3%
2Y CAGR
-0.7%
3Y CAGR
6.1%
5Y CAGR
49.4%
7Y CAGR
57.7%
10Y CAGR
48.5%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
21.6%
2Y CAGR
16.1%
3Y CAGR
13.3%
5Y CAGR
39.7%
7Y CAGR
73.1%
10Y CAGR
28.6%
Total Current Liabilities Annual Cr growth is stable compared to historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-85%
2Y CAGR
-63.7%
3Y CAGR
-47.9%
5Y CAGR
-1%
7Y CAGR
27.1%
Total ShareHolders Funds Annual is falling faster than historical averages.

Sanara MedTech Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Sanara MedTech Inc Book Value Per Share is $1 which is growth of -84.9% YoY.

  • NEUTRAL

    ROE Sanara MedTech Inc ROE is 0% which is growth of 0% YoY.

Sanara MedTech Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--11.93%-6.38%-16.29%-34.28%-41.60%-39.75%-27.83%8.76%-38.03%-111.36%
ROE Ann. %
-
-
--22.95%-9.93%-21.91%-43.06%-623.88%--407.72%---
ROIC %
-
-
--0.40.1-9-10.8-3.6--16.4---
OPM Ann. %
-
-
8.87%-9.98%-11.79%-26.68%-30.55%-32.11%-22.35%-8.38%2.26%-4.75%-28.62%
Inventory Turnover Ratio Ann.
-
-
-2.21.92.31.51.73.21.41.52.52.2
Asset Turnover Ann. %
-
-
-1.110.911.51.72.22.93.12.3
Working Capital Turnover Ann.
5.4%
-16%
6.94.812.45.91.316.51.910.2-80.99.2-11.2
Quick Ratio Ann.
-
-
-1.911.33.60.832.30.61.20.4
Current Ratio Ann.
-
-
-2.21.41.64.11.33.42.411.40.8
Interest Coverage Ratio Ann.
-
-
--2.2-8.3-48-11,242-384.6-25.8-5.93.6-1.4-6.6
LT Debt To Equity Ann.
-
-
-0.80.2000.1-1.4---
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Sanara MedTech Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity Sanara MedTech Inc Dec-2025 Cash From Operating Activity is $7 Million which is growth of 28639.2% YoY.

  • NEGATIVE

    Net Cash Flow Sanara MedTech Inc Dec-2025 Net Cash Flow is $1 Million which is growth of -93.5% YoY.

Sanara MedTech Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
-
6.8-0-3.3-5.6-4.8-4-2.20.3-0.10.4-1.2
⌄
-
-
-15-6.6-10.2-3.5-5.3-2.7-1.2-0-0.1-0
⌄
-
71.5%
8.917.49.6-0.628.30.69.8-0.10.20.9
Cash Plus Cash Eqv. End Of Year Ann.
22.6%
101.5%
16.615.95.2918.70.56.60.70.50.80.2
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
0.710.7-3.8-9.718.2-6.26.40.3-0.40.7-0.3
Cash Plus Cash Eqv. Begin Of Year Ann.
-5.3%
19.2%
15.95.2918.70.56.60.20.50.80.20.5
Income Tax Paid Supplemental Data Ann.
-
-
----
Interest Paid Supplemental Data Ann.
-
-
3.41.60.3000.10.1
Capex Ann.
-
-
-4.7-0.2-0.3-0.8-0.8-1.6-1.7-0-0.1-0
Issuance Of Capital Stock Ann.
-
-
--0.928.9--0.10.50.8
Issuance Of Debt Ann.
-
82.1%
1229.39.70.80.62.2--1.3
Repayment Of Debt Ann.
-
-
-1.7-9.8--0.8-2.2-0.2-0.2-1.2
Repurchase Of Capital Stock Ann.
-
-
----------
Free Cash Flow Ann.
-
-
2.1-0.3-3.5-6.3-5.6-5.7-3.90.3-0.20.4-1.2
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
7Y CAGR
56.2%
Cash from Operating Activity Annual growth is higher than historical averages.
Cash from Financing Act. Ann.
1Y CHG
-48.9%
2Y CAGR
-3.7%
5Y CAGR
71.5%
10Y CAGR
25.8%
Cash from Financing Annual Activity is falling faster than historical averages.
×